ArticleCancer science2025

LTF as a Potential Predictive Biomarker for Durable Benefit From First-Line Chemo-Immunotherapy in Small Cell Lung Cancer.

Shimo Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.